Australian Competition and Consumer Commission v Medibank Private Limited

Link copied
Case Copied 76 min read

FEDERAL COURT OF AUSTRALIA

Australian Competition and Consumer Commission v Medibank Private Limited [2017] FCA 1006

File number: VID 642 of 2016
Judge: O’CALLAGHAN J
Date of judgment: 30 August 2017
Catchwords: CONSUMER LAW – private health insurance – contract for the provision of insurance in respect of in-hospital pathology and radiology services – where insurer met the out-of-pocket expenses incurred by policyholders in respect of in-hospital pathology and radiology services through direct payment arrangements with providers of those services – where insurer decided to terminate certain of those payment arrangements and, upon termination of those arrangements, to pay a reduced proportion of the provider’s actual charges – whether conduct misleading or deceptive in contravention of ss 18, 29(1)(g), 29(1)(m) or 34 in Sch 2 of the Competition and Consumer Act 2010 (Cth) (“Australian Consumer Law”) – whether conduct unconscionable in contravention of s 21 of the Australian Consumer Law
Legislation:

Competition and Consumer Act 2010 (Cth), Sch 2, ss 18, 21, 29(1)(g), 29(1)(m), 34

Evidence Act 1995 (Cth), s 191

Health Insurance Act 1973 (Cth), ss 3 (definitions of “approved pathology practitioner”, “item”, “medicare benefit”, “medical practitioner”, “professional service” and “table”), 10, 126

Private Health Insurance Act 2007 (Cth) (as at 1 July 2014), Pts 3-2, 3-3, 3-4, 4-2 (Div 118), Pt 4-3 (Div 126) and Pt 4-4 (Div 134)

Private Health Insurance (Prudential Supervision) Act 2015 (Cth), Pt 2, Divs 2 and 3, Pt 3, Div 2

Private Health Insurance (Complying Product) Rules 2010(No. 2) (Cth) (as at 1 July 2014), r 13, Schs 1-4

Private Health Insurance (Benefits Requirements) Rules 2011 (Cth) (as at 24 July 2014), Pt 2, Schs 1-5

Cases cited:

Australian Competition and Consumer Commission v Commonwealth Bank of Australia (2003) 133 FCR 149

Australian Competition and Consumer Commission v Lux Distributors Pty Ltd [2013] FCAFC 90

Australian Competition and Consumer Commission v Simply No-Knead Franchising Pty Ltd (2000) 104 FCR 253

Australian Competition and Consumer Commission v TPG Internet Pty Ltd (2013) 250 CLR 640

Australian Competition and Consumer Commission v 4WD Systems Pty Ltd [2003] FCA 850; 200 ALR 491

Bing! Software Pty Ltd v Bing Technologies Pty Ltd (2009) 180 FCR 191

1           Butcher v Lachlan Elder Realty (2004) 218 CLR 592

2           Campbell v Backoffice Investments (2009) 238 CLR 304

Chase Manhattan Overseas Corp v Chase Corp Limited (1986) 12 FCR 375

Health Insurance Commission v Peverill (1994) 179 CLR 226

Metz Holdings Pty Ltd v Simmac Pty Ltd (No 2) [2011] FCA 981

NRM Corporation Pty Ltd v Australian Competition and Consumer Commission [2016] FCAFC 98

Perdaman Chemicals and Fertilisers Pty Ltd v ICICI Bank Ltd [2013] FCA 175

SAP Australia Pty Ltd v Sapient Aust Pty Ltd [1999] FCA 1027

SAP Australia Pty Ltd v Sapient Australia Pty Ltd  [1999] FCA 1821; (1999) 169 ALR 1

Trade Practices Commission v Optus Communications Pty Ltd (1996) 64 FCR 326

Wong v Commonwealth (2009) 236 CLR 573

Biggs A, “Medicare: a Quick Guide” (Department of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Australian Competition and Consumer Commission v Medibank Pr... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2017] FCA 1006
Decision Date

CaseChat Overview and Summary

The Australian Competition and Consumer Commission brought a case against Medibank Private Limited concerning the insurer's conduct regarding the provision of in-hospital pathology and radiology services. The ACCC alleged that Medibank's actions, specifically terminating certain direct payment arrangements with service providers and subsequently paying a reduced proportion of the providers' charges, constituted misleading or deceptive conduct under various sections of the Competition and Consumer Act 2010. Additionally, the ACCC argued that Medibank's conduct was unconscionable. The central issues before the court involved whether Medibank's actions violated sections 18, 29(1)(g), 29(1)(m), and 34 of the Australian Consumer Law and whether the conduct breached section 21 of the same law by being unconscionable.

The court examined the evidence presented, including market research and internal communications at Medibank, which suggested that a significant portion of Medibank's members had limited understanding of private health insurance and out-of-pocket expenses. Despite these findings, the court determined that Medibank's decision not to communicate with members about the changes was a matter of business judgment and did not amount to unconscionable conduct. The court held that while some members might disagree with the decision, it did not meet the threshold of unconscionability required by law. Consequently, the court dismissed the ACCC's case, ruling that Medibank's actions did not contravene the Australian Consumer Law.

The court ordered that the proceeding be dismissed with costs, effectively concluding that Medibank's conduct did not warrant the ACCC's intervention. The decision underscores the importance of business judgment in such matters and highlights the high threshold for establishing unconscionable conduct under the Australian Consumer Law.

Orders

Orders of the court

1. The proceeding be dismissed with costs.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Evidence

Evidence Before The Court

I will now turn to deal in detail with the evidence relevant to the applicant’s diagnostic cover representation case.Evidence relevant to the applicant’s diagnostic cover representation case Medibank offers a range of health insurance products to retail customers. The products are “differentiated” in three main ways. First, the products are differentiated by whether they provide hospital cover, extras cover or both. Hospital cover provides benefits towards the costs of treatment at a hospital, as well as some services arranged or provided by a hospital in a non-hospital setting. Extras cover, sometimes also called “general” or “general treatment” cover, provides benefits towards the costs of out-of-hospital treatment, such as dental, optical and physiotherapy services. Secondly, the products are differentiated by the types of medical procedures that are covered by the policy. Medibank’s policies cover a procedure when the policy pays benefits towards the costs incurred by the member when having that procedure. Thirdly, the products are differentiated by the number of persons included within the insurance cover, including “Singles” products, “Couples” products, “Family” products and “Single Parents” products. ahm offers a range of health insurance products to retail customers, which are distinguished in three main ways. First, products are distinguished by whether they apply to hospital, extras or both. This category applies in much the same way as detailed at [101] above. Secondly, ahm’s hospital products apply to different types of medical procedures within hospitals, depending on the level of cover (e.g. “Top Hospital” or “Budget Hospital”). Hospital products offered by ahm have four types of membership – “Singles”, “Couples”, “Family” and “Single Parent”. Medibank offers its policies for sale to Australian consumers through various channels, including, primarily, on Medibank and ahm websites and via sales representatives operating by telephone, in-store and through web-chat. Medibank provides at least the following documents to reach new members upon purchasing a policy. First, for Medibank branded policies, new members receive a document entitled “Cover Summary” and for ahm branded policies, a document entitled “Quick Guide”, which identifies the main benefits of the member’s policy and refers members to the Member Guide for more information (Cover Summaries). Both Medibank and ahm new members receive a Member Guide. The Member Guide is also available to prospective and current members. For Medibank branded policies, the Member Guide is found in the “Health insurance” section of the Medibank website, as part of the “Forms & brochures” pages and in Medibank’s retail stores. For ahm branded policies, the Member Guide was found in the “Help & downloads” section of the ahm website, as part of the “Downloads” pages. Typical examples of Member Guides, Cover Summaries, webpages and materials available for use by in-store retail staff and by third-party telephone sales representatives were in evidence and are described in more detail below.

Decision

Reasons for decision

Ultimately, that evidence, which I unhesitatingly accept, demonstrates that the decision not to communicate with members (about which the applicant complains) was a decision made in the context of the exercise by the relevant committee of its business judgment. Some may agree with it, some may disagree with it, but, in my view, there was nothing remotely unconscionable about it.CONCLUSION The applicant’s case will accordingly be dismissed, with costs.

Ratio Decidendi

Legal Principle Established

After implementation of the decision, Medibank received a number of complaints from members.Consideration – unconscionability The submissions in respect of the evidence, which I have outlined and with which it is necessary to deal are as follows.Market research and Medibank’s knowledge of consumers I turn first to the market research upon which the applicant placed much store. It is not necessary to recite that evidence in any detail, because ultimately the applicant’s case was that the relevant reports and internal correspondence about them proved a series of propositions concerning information known to Medibank from early 2014 onwards, which made Medibank’s decision not to notify members of the change unconscionable. Those propositions, which rely principally upon the Sibbick memo referred to earlier and, to a lesser extent, evidence given by Dr Wilson in cross-examination, are as follows: (1)large proportions of the member base do not have a good understanding of private health insurance in general; (2)two thirds of members paid an excess in connection with hospital admissions; (3)large proportions of members who paid an excess did not expect to pay any medical out-of-pocket expenses;(4)over half of members who claimed on hospital policies (claimers) experienced medical out-of-pocket expenses;(5)one third of claimers who experienced a medical out-of-pocket expense were surprised by it;(6)around half of claimers who experienced a medical out-of-pocket expense did not qualify as having given informed financial consent to the out-of-pocket charge; (7)over half of claimers considered that medical gaps were not easy to understand; (8)seven in 10 members had no discussions about medical out-of-pocket expenses prior to their admission;(9)for claimers over 64 years of age, around eight in 10 did not contact Medibank; (10)around half of Medibank members (generally) were in the 64 year plus cohort and around 20% were on incomes less than $50,000; (11)15% of claimers who paid a medical out-of-pocket expense only, and 33% of claimers who paid a medical out-of-pocket expense and an excess, would consider switching health funds as a result; (12)over half of non-claimers felt they had a vague or poor understanding of out-of-pocket expenses prior to being informed (during surveys);(13)over half of non-claimers expected to pay no out-of-pocket expenses other than their excess; (14)one third of members would switch doctors/specialists to reduce/avoid medical out-of-pocket expenses; (15)one third of claimers who paid medical out-of-pocket expenses considered it was Medibank’s responsibility to inform them about the out-of-pocket expenses in advance; (16)if educated about the opportunity to discuss out-of-pocket expenses prior to hospital admission, 80% would do so and 80% of that cohort would approach Medibank;(17)the “surprise” of out-of-pocket expenses left a greater negative impression for members that the amount of out-of-pocket expenses; (18)members’ first interaction with in-hospital diagnostic service providers is likely to be at the hospital; and(19)members typically first became aware of medical out-of-pocket expenses when they got home from hospital and began to receive medical bills.